logo
Breathing easy, by preparing well

Breathing easy, by preparing well

BENGALURU: UST a few hundred fresh Covid-19 cases may not set off panic yet — but what happens if the numbers suddenly double or triple, like they did before? Are we really ready this time?
A reality check by TNIE reveals that Karnataka is not taking any chances. After witnessing the devastation caused by previous Covid-19 waves, particularly the oxygen crisis during the second wave, the health and medical education department are moving swiftly to ensure that critical infrastructure built during the pandemic doesn't fall into disuse.
Take the Pressure Swing Adsorption (PSA) oxygen generating plants, for instance. During the peak of the pandemic, 243 such plants were installed across district and taluk hospitals to ensure a steady oxygen supply. Each plant came with an annual maintenance cost of around Rs 5 lakh. In the months that followed, as Covid cases declined, many of these units were neglected and became defunct.
But now, with cases gradually rising again in neighbouring countries and also within Karnataka, the state has reactivated most of these plants. District health officials have been instructed to carry out maintenance checks and ensure they are fully operational — a move that seems like a lesson learnt against the overall scramble seen during earlier waves.
The state has kept its systems warm — from oxygen infrastructure and isolation wards to rapid testing capabilities — and officials say they are prepared to scale up within days if required. Rather than treating preparedness as a 'crisis-only' strategy, the state is treating it as a permanent feature of its health system. The panic button has been pressed early — not because the situation is dire yet, but because the cost of being unprepared is one the state cannot afford to repeat, officials say.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Majhi launches ‘zero accident day' to enhance road safety
Majhi launches ‘zero accident day' to enhance road safety

Time of India

time38 minutes ago

  • Time of India

Majhi launches ‘zero accident day' to enhance road safety

1 2 Bhubaneswar: In a significant move towards enhancing road safety, chief minister Mohan Charan Majhi on Tuesday launched the 'Zero Accident Day' initiative. He also launched multiple road safety programmes and infrastructure developments worth around Rs 575.77 crore. Speaking at the event held at Lok Seva Bhavan here, Majhi emphasised that road accidents affect not just individuals but the entire economy. "About 75% of accident-related deaths in India are due to speeding," he stated, urging citizens to strictly adhere to road safety rules. "Accidents impact not just families or states, but the entire economy. It is not just an individual loss, but a collective one. Therefore, I urge everyone to strictly follow all road-related rules from the time you leave home until you return, ensuring a safe journey," he said. The event marked the inauguration of 11 automated driving testing systems (ADTS) across various districts, implemented at a cost of Rs 24 crore. The CM also launched the second phase of the Disha (Driving Electronic Enforcement to Save Human Lives) project, worth Rs 215 crore, which will cover 485 km of national and state highways. In a major boost to public transportation, 15 super premium buses, christened 'Shri Jagannath Express', were introduced at a cost of Rs 27.3 crore. These buses will connect various cities including Puri, Ayodhya, Tirupati, and Hyderabad. The state's first automated vehicle testing centre was unveiled in Cuttack, with plans to establish 20 more centres at an allocated budget of Rs 211 crore. The govt also inaugurated the Atal Bus Stand in three locations — Basudevpur, Dhamra and Basta. Commerce and transport minister Bibhuti Bhushan Jena highlighted the govt's commitment to safe transport. "When we discuss Odisha's development, safe and robust transport is crucial," he said. The event saw participation from 'Zero Accident Day' brand ambassadors, including Digapahandi MLA Siddhanta Mahapatra and Padma Shri awardee Sudarsan Pattnaik, who shared messages on road safety awareness. Five individuals — Abinash Panigrahi, Bishwaranjan Padhi, Panchanan Das, Srinivas Behera and Savita Rani Parida — were honoured for their efforts in transporting accident victims to hospitals. A CMO statement said the 'Zero Accident Day' initiative, developed in collaboration with IIT-Madras, will continue until June 28.

Overlapping symptoms make Cov diagnosis difficult without tests
Overlapping symptoms make Cov diagnosis difficult without tests

Time of India

time39 minutes ago

  • Time of India

Overlapping symptoms make Cov diagnosis difficult without tests

Kolkata: The overriding symptoms of Covid during the current surge were a low-grade, persistent fever, along with a mild cough, which could be deceptive, warned doctors. While it made a vast majority ignore the symptoms and take over-the-counter medicines, for some, the fever refused to subside. It was the continuing fever that led many to consult physicians. Most of those testing Covid positive on admission to hospitals for other ailments were also screened at hospitals due to their fever. Covid cases have been rising in Bengal over the past week. The state logged 319 cases in the past seven days, taking the number of active cases to 331 on Monday. Unlike the first three waves, when Covid came with loss of smell and taste, accompanied by high fever, severe cough and pneumonia, the symptoms of the current spike were muted and flu-like, said doctors. With a runny nose and a sore throat, symptoms in most were milder than that during the pandemic, said CMRI pulmonology director Raja Dhar. "Mild symptoms led many to ignore it, which could be risky at a time, when cases are proliferating. One should get tested, and if the result turns positive, the patient should isolate, especially if there are elders in the family. Screening should be stricter for elderly people with comorbidities, and if the fever and cough persist beyond four to five days, hospitalization is advised as symptoms could worsen quickly," said Dhar. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Beyond Text Generation: An AI Tool That Helps You Write Better Grammarly Install Now Undo CMRI has seven Covid patients admitted. Manipal Hospitals infectious diseases physician Sayan Chakrabarty agreed. "The symptoms are flu-like, but for some, the fever persists. Those patients are getting tested, and many tested positive. While severe cases have been rare so far, rising numbers could lead to a spurt," he added. Five Covid patients, admitted to Manipal's different units, have been discharged. Covid pneumonia has been rare this time, said Charnock Hospital pulmonologist Soumya Sengupta. "Most patients have a cough and low fever. Even the elders in hospital who tested positive have muted Covid symptoms. Most are being treated for their comorbidities. During the pandemic, a vast majority of senior citizens had severe Covid symptoms, including pneumonia," said Sengupta. Dhar pointed out that the Jn.1 variant of the Omicron, now believed to be in circulation, was highly transmissible though less virulent. "But it is safe to isolate yourself for five days on testing positive and take symptomatic drugs. Symptoms are likely to remain mild till this wave blows over in about a fortnight. But even mild Covid may aggravate comorbidities, especially those related to lungs," he said.

New Covid vaccine developed by USA researchers is ready to fight Coronavirus. How effective it is?
New Covid vaccine developed by USA researchers is ready to fight Coronavirus. How effective it is?

Time of India

time39 minutes ago

  • Time of India

New Covid vaccine developed by USA researchers is ready to fight Coronavirus. How effective it is?

Amid fresh surge in Covid-19 cases, a team of US researchers has developed a new type of mRNA vaccine that is more scalable and adaptable to tackle continuously evolving viruses such as SARS-CoV-2 and H5N1. While the currently available mRNA vaccines are highly effective at inducing an immune response against Covid , they present challenges like the high amount of mRNA needed to produce them and the constantly evolving nature of the pathogen. "The virus changes, moving the goal post, and updating the vaccine takes some time," said senior author Suresh Kuchipudi, chair of Infectious Diseases and Microbiology at the University of Pittsburgh School of Public Health. To address these challenges, the researchers created a proof-of-concept Covid vaccine using what's known as a "trans-amplifying" mRNA platform. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Pare a neuropatia: descubra como NeuroFit Undo In this approach, the mRNA is separated into two fragments -- the antigen sequence and the replicase sequence -- the latter of which can be produced in advance, saving crucial time in the event a new vaccine must be developed urgently and produced at scale. In addition, the researchers analysed the spike-protein sequences of all known variants of the SARS-CoV-2 for commonalities, rendering what's known as a "consensus spike protein" as the basis for the vaccine's antigen. Live Events In mice, the vaccine induced a robust immune response against many strains of SARS-CoV-2. "This has the potential for more lasting immunity that would not require updating, because the vaccine has the potential to provide broad protection," said Kuchipudi. "Additionally, this format requires an mRNA dose 40 times less than conventional vaccines, so this new approach significantly reduces the overall cost of the vaccine." The study, published in the journal npj Vaccines could inform more efficient vaccine development for other constantly evolving RNA viruses with pandemic potential, Kuchipudi said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store